Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$3.04 - $6.01 $161,436 - $319,155
-53,104 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$5.9 - $7.44 $44,840 - $56,544
7,600 Added 16.7%
53,104 $316,000
Q2 2021

Aug 11, 2021

SELL
$5.78 - $9.6 $49,326 - $81,926
-8,534 Reduced 15.79%
45,504 $306,000
Q1 2021

May 17, 2021

BUY
$5.67 - $12.54 $48,387 - $107,016
8,534 Added 18.75%
54,038 $393,000
Q4 2020

Feb 16, 2021

BUY
$5.28 - $9.59 $240,261 - $436,383
45,504 New
45,504 $244,000

Others Institutions Holding NHWK

# of Institutions
1
Shares Held
5K
Call Options Held
0
Put Options Held
0

About NightHawk Biosciences, Inc.


  • Ticker NHWK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,661,500
  • Market Cap $4.11M
  • Description
  • NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...
More about NHWK
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.